Clonidine extended-release (US brand name Kapvay® and generic) is a centrally acting alpha2-adrenergic agonist. Here is basic information about this medication.
Treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications
Dosage needs to be individualized according to therapeutic needs and response. Initiated with 0.1 mg at bedtime and then adjusted in 0.1 mg/day increments at weekly intervals until the desired response is achieved. Doses should be taken twice a day, with either an equal or higher split dosage being given at bedtime.
Starting: 0.1 mg/day at bedtime and then adjusted weekly as below until desired response
Morning: 0.1 mg/day, Bedtime: 0.1 mg/day (Total: 0.2 mg/day)
Morning: 0.1 mg/day, Bedtime: 0.2 mg/day (Total: 0.3 mg/day)
Morning: 0.2 mg/day, Bedtime: 0.2 mg/day (Total: 0.4 mg/day)
- Tablets should not be crushed, chewed or broken before swallowing.
- Do not substitute for other clonidine products on a mg-per-mg basis, because of differing pharmacokinetic profiles
- Doses higher than 0.4 mg/day have not been evaluated and therefore not recommended.
- Since it has not been systematically evaluated for long-term maintenance treatment, physicians should periodically assess usefulness if prescribed for extended periods.
Total dose should be tapered in decrements of no more than 0.1 mg every 3 to 7 days
Dosage forms and strengths
Extended-release tablets (brand name and generic): 0.1 mg and 0.2 mg
Important! Please refer to the full Prescribing Information (see link below) before prescribing this medication.
Copyright 2016, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other lay persons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.